Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

COVID-19 ‘Hot Spots’ In US To Receive $5Bn To Test Nursing Home Residents, Staff

Executive Summary

The US HHS last week said it will start providing states with high rates of COVID-19 cases with additional diagnostics and equipment to test nursing home residents.

You may also be interested in...



Clock Ticking For Manufacturers To Apply For Pandemic Provider Relief Funds

Previously ineligible health care providers and firms that supply telehealth equipment for use in counseling patients during the pandemic are eligible.

HHS Conditions Hospital COVID-19 Relief Payments On No Surprise Billing

A new US HHS report highlights ways the agency and coronavirus relief legislation are seeking to prevent high-cost surprise billing of patients with the novel coronavirus.

White House To Deliver 25 Million Face Masks To Low-Income Americans

The White House will be spending $86m to provide tens of millions of coronavirus masks to poorer American households.

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

MT142494

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel